Adding CBD to Low-Dose Buprenorphine Boosted Pain Relief and Reduced Breathing Suppression in Rats | Research

The takeaway

Combining CBD with a sub-therapeutic dose of buprenorphine produced significant pain relief in a rat model of chronic nerve pain, while CBD also reduced the breathing suppression typically caused by buprenorphine.

Pain management researchers, opioid safety researchers, anesthesiologists

CBD both enhanced pain relief and reduced breathing suppression when combined with low-dose buprenorphine

What the researchers found

The combination of a sub-analgesic buprenorphine dose and CBD produced statistically significant increases in pain threshold compared to either compound alone. CBD attenuated buprenorphine-induced respiratory depression as measured by blood gas analysis and oxygen saturation. CBD increased buprenorphine blood levels by approximately 30% but this pharmacokinetic interaction did not account for the analgesic or respiratory effects.

Why it matters

Opioid overdose deaths remain a public health crisis, largely due to respiratory depression. A combination that provides pain relief at lower opioid doses while also protecting breathing could represent a fundamentally safer approach to pain management.

The numbers in context

Sub-analgesic buprenorphine + CBD produced significant pain relief (p < 0.05 vs saline); CBD attenuated buprenorphine-induced respiratory depression in blood gas (p < 0.05) and O2 saturation (p < 0.05); CBD increased buprenorphine AUC by ~30% (p = 0.008); no changes in other pharmacokinetic parameters; CBD did not attenuate morphine-induced respiratory depression

How the study worked

Chronic constriction injury model of neuropathic pain in rats assessed via Von Frey testing. Pharmacokinetic study measured drug-drug interactions. Respiratory depression assessed in two separate studies using blood gas analysis and oxygen saturation monitoring.

What this study cannot tell us

Rat model may not translate to humans, specific to buprenorphine (did not work with morphine), the 30% increase in buprenorphine blood levels could have clinical implications, single pain model tested, no data on tolerance or long-term use

How to read the evidence

Preclinical study with multiple confirmed endpoints (pain, respiratory, pharmacokinetic); strong animal data but no human validation yet

When this study was published

Published 2025

The bigger picture

The opioid crisis has driven demand for safer pain medications. A fixed-dose combination of CBD and low-dose buprenorphine that provides effective pain relief while reducing overdose risk could address both the pain management and safety concerns simultaneously.

Questions still open

Will the opioid-sparing and respiratory protection effects translate to humans? Why did CBD protect against buprenorphine but not morphine respiratory depression? What is the optimal CBD-to-buprenorphine ratio for clinical use?

Common questions

Can CBD make opioid pain relievers safer?

In rats, adding CBD to a low dose of buprenorphine provided significant pain relief while also reducing the breathing suppression that makes opioids dangerous. This effect was not due to a simple drug interaction.

Does CBD work with all opioids to reduce respiratory depression?

No. In this study, CBD attenuated respiratory depression caused by buprenorphine but not morphine, suggesting the protective effect may be specific to certain opioids.

Read the original research

Combination of Cannabidiol and Low-Dose Buprenorphine Suggests Synergistic Analgesia and Attenuates Buprenorphine-Induced Respiratory Depression.

Cannabis and cannabinoid research, 10(5), 621-630

View on PubMed ↗Publisher’s paper ↗

Citation

Briones, Marisa S; DeYoung, Dustin Z; Heinzerling, Keith G. (2025). Combination of Cannabidiol and Low-Dose Buprenorphine Suggests Synergistic Analgesia and Attenuates Buprenorphine-Induced Respiratory Depression.. Cannabis and cannabinoid research, 10(5), 621-630. https://doi.org/10.1089/can.2025.0004